SYSTANE PRO Preservative-Free 

 

With science this advanced, it’s a simple choice

 

Behind every drop is 20 years of dry eye research, resulting in our most comprehensive, long-lasting formula yet.

How SYSTANE® PRO PF Works                                   Clinical Evidence                                   Resources

Make a simple choice with SYSTANE® PRO PF

 

The preservative-free triple-action formula hydrates, restores, and protects dry eyes.

 

Alt text
Alt text

 

Up to 12 hours
of dry eye relief*

Alt text
Alt text

 

For all types of dry eye: aqueous, evaporative, mixed

Alt text
Alt text

 

Preservative-free

Alt text
Alt text

 

Contact lens friendly†

With up to 12 hours of dry eye relief* patients may dose as little as twice a day, fitting SYSTANE® PRO PF by Alcon seamlessly into their daily routine.

 

Why ECPs choose SYSTANE® PRO PF

Dr. Jennifer Harthan, OD, FAAO, FSLS*

Glenview Vision Care, Glenview, IL

 

“One of the things I love about SYSTANE® PRO PF is...it’s suitable for all patients with all types of dry eye...so you don’t have to think, is this artificial tear good for this person?”

 

Dr. Douglas Devries, OD*

Eye Care Associates of Nevada, Sparks, Nevada

 

“Patients have busy lifestyles. To have a formulation that’s going to last up to 12 hours†—that’s the difference between getting through your workday and not getting through your workday.”

 

*Dr. Jennifer Harthan and Dr. Douglas Devries are paid consultants for Alcon.

†47% of patients experience meaningful symptom relief at 12 hours (n=153).

Witness the evolution of ocular surface science

 

See how SYSTANE® PRO Preservative-Free works: Supporting the active ingredient propylene glycol, the HP-Guar meshwork, lipid nanodroplets, and hyaluronate work together to hydrate, restore, and protect1-7—providing dry eye relief for up to 12 hours.*

 

Propylene Glycol

 

The active ingredient that lubricates and soothes dry eyes.1

Alt text

The difference is in the data

 

 

A clinical study demonstrated that SYSTANE® PRO Preservative-Free delivers across 3 key measures of dry eye relief to hydrate, restore, and protect all types of dry eye.

 

 

See how SYSTANE® PRO PF hydrates, restores, and protects below:

    Hydrates

     

    84% of subjects strongly agreed or agreed that their eyes felt hydrated1*†
     

    *Based on a Phase 3, single-arm, open-label, multicenter study in which subjects with dry eye disease instilled at least 1 drop of SYSTANE® PRO PF into each eye at least 4 times daily for 30 days; n=158.

    †Responded “Strongly agree” or “Agree” to the Likert question, “Do your eyes feel hydrated?,” immediately after SYSTANE® PRO PF instillation.

     

    Reference: 1. Alcon data on file, 2025.

    Restores

     

    NITBUT significantly improved from baseline on Days 1 and 301*
     

    *Based on a Phase 3, single-arm, open-label, multicenter study in which subjects with dry eye disease instilled at least 1 drop of SYSTANE® PRO PF into each eye at least 4 times daily for ~30 days; n=158. The mean change from baseline on Day 1 or Day 30 did not meet the established threshold for clinically meaningful change of 2.5 seconds; P<0.0001.

     

    Reference: 1. Alcon data on file, 2025.

    Protects

     

    Statistically significant improvement in DES Score following a single drop of SYSTANE® PRO PF in each eye, even up to 12 hours1*†

    *Based on a Phase 3, single-arm, open-label, multicenter study in which subjects with dry eye disease instilled at least 1 drop of SYSTANE® PRO PF into each eye at least 4 times daily for 30 days; n=158.

    †P<0.0001 vs. baseline; DES, Dry Eye Symptoms.

     

    Reference: 1. Alcon data on file, 2025.

    How SYSTANE® PRO PF compares

     

    Alt text

    *47% of patients experience meaningful symptom relief at 12 hours (n=153).

    †Based on label claim or publicly available promotional materials for Refresh Optive Mega-3, Blink Triple Care, and iVizia for dry eyes.

    ^Trademarks are the property of their respective owners.

    Alt text

    *Based on in vitro measurements.

    ^Trademarks are the property of their respective owners.

    Patient savings

     

    Help your patients try SYSTANE® PRO Preservative-Free. Sign up to order coupons sent directly to your office.

    Alt text

    A clearer path to diagnosing dry eye disease (DED)

     

     

    DED can present in different ways, making diagnosis less straightforward. Released by the Tear Film & Ocular Surface Society (TFOS), the TFOS Dry Eye Workshop (DEWS) III recommendations outline a path from patient history and symptom screening to clinical evaluation.12

    Patient history + risk factors → Symptom screening → Homeostasis marker testing

     

     

     

    Looking for more dry eye disease resources?

     

    Explore additional educational tools and videos from the World Council of Optometry, presented in partnership with Alcon, including resources informed by TFOS DEWS III guidance.



    Dry eye relief starts with choosing the right artificial tear

     

     

    Artificial tears are a cornerstone of dry eye treatment. Choosing the right one depends on several key factors—from the patient’s dry eye type and symptom presentation to frequency of use and contact lens compatibility.13

    SYSTANE® PRO PF is:

    • Preservative-free Long-lasting dry eye relief For all types of dry eye: aqueous, evaporative, mixed presentation Contact lens friendly*

    Formulated to hydrate, restore, protect, and provide up to 12 hours† of dry eye relief, SYSTANE® PRO PF is a simple choice.

     

    *Not a rewetting drop.

    †47% of patients experience meaningful symptom relief at 12 hours (n=153).

    Alt text

    Why SYSTANE®?

     

    As part of Alcon's #1 doctor recommended family of brands,* SYSTANE® offers a range of formulas that provide real, long-lasting relief for patients with all types of dry eye.

     

     

    *Based on IQVIA ProVoice Survey of Eye Care Professionals, 12 months ending December 31, 2025.

    Alt text

      1. FDA - OTC Ophthalmic Monograph M018: April 2022.

      2. Kesavan S, et al. Macromolecules. 1992;25(7):2026-2032.

      3. Ubels JL, et al. Curr Eye Res. 2004;28(6):437-444.

      4. Rangarajan R, et al.  J Ocul Pharmacol Ther. 2019;35(1):32-37. 

      5. Rangarajan R, et al. J Ocul Pharmacol Ther. 2015;31(8):491-497.

      6. Ng A, et al. Clin Ophthalmol. 2018;12:695-700.

      7. Moon SW, et al. Cornea. 2010;29(12):1430-1435.

      8. Alcon data on file, 2025.

      9. Alcon data on file, 2025.

      10. Alcon data on file, 2025.

      11. Alcon data on file, 2024.

      12. Wolffsohn JS, et al. TFOS DEWS III: Diagnostic Methodology. Am J Ophthalmol. 2025;279:387-450. doi:10.1016/j.ajo.2025.05.033

      13. Pult H, Wolffsohn JS. Ocul Surf. 2019;17(4):817-821.

      ©2026 Alcon Inc. US-SAF-2600116